David A. Isenberg
AuthID: R-006-E33
11
TITLE: A review of the development of gangrene in patients with systemic lupus erythematosus - A 44-year follow-up study Full Text
AUTHORS: Rua, Joana; Isenberg, David;
PUBLISHED: 2023, SOURCE: LUPUS, VOLUME: 32, ISSUE: 7
AUTHORS: Rua, Joana; Isenberg, David;
PUBLISHED: 2023, SOURCE: LUPUS, VOLUME: 32, ISSUE: 7
INDEXED IN:
Scopus
WOS
12
TITLE: Approach to vaccination in systemic lupus erythematosus on biological treatment
AUTHORS: Yildirim, Resit; Oliveira, Tatiana; Isenberg, David Alan;
PUBLISHED: 2023, SOURCE: ANNALS OF THE RHEUMATIC DISEASES
AUTHORS: Yildirim, Resit; Oliveira, Tatiana; Isenberg, David Alan;
PUBLISHED: 2023, SOURCE: ANNALS OF THE RHEUMATIC DISEASES
INDEXED IN:
WOS
13
TITLE: Promising Experimental Treatments for Lupus Nephritis: Key Talking Points and Potential Opportunities Full Text
AUTHORS: Neves, Ana; Viveiros, Luisa; Venturelli, Veronica; Isenberg, David A.;
PUBLISHED: 2023, SOURCE: RESEARCH AND REPORTS IN UROLOGY, VOLUME: 15
AUTHORS: Neves, Ana; Viveiros, Luisa; Venturelli, Veronica; Isenberg, David A.;
PUBLISHED: 2023, SOURCE: RESEARCH AND REPORTS IN UROLOGY, VOLUME: 15
INDEXED IN:
Scopus
WOS
14
TITLE: Major determinants of prolonged remission in systemic lupus erythematosus: retrospective study over a 41+year period
AUTHORS: Durao Carvalho, Goncalo; Fernandez Gonzalez, Raquel; Goulden, Bethan; Farinha, Filipa; Isenberg, David;
PUBLISHED: 2022, SOURCE: RHEUMATOLOGY
AUTHORS: Durao Carvalho, Goncalo; Fernandez Gonzalez, Raquel; Goulden, Bethan; Farinha, Filipa; Isenberg, David;
PUBLISHED: 2022, SOURCE: RHEUMATOLOGY
INDEXED IN:
WOS
15
TITLE: Adverse events of treatment with rituximab in patients with myositis
AUTHORS: Gilaberte, Sergio; Rua, Joana; Isenberg, David;
PUBLISHED: 2022, SOURCE: RHEUMATOLOGY, VOLUME: 62, ISSUE: 2
AUTHORS: Gilaberte, Sergio; Rua, Joana; Isenberg, David;
PUBLISHED: 2022, SOURCE: RHEUMATOLOGY, VOLUME: 62, ISSUE: 2
INDEXED IN:
Scopus
WOS
16
TITLE: The use of combination monoclonal antibody therapies in lupus-where are we now?
AUTHORS: Rua, Joana; Dall'Era, Maria; Isenberg, David;
PUBLISHED: 2022, SOURCE: RHEUMATOLOGY, VOLUME: 62, ISSUE: 5
AUTHORS: Rua, Joana; Dall'Era, Maria; Isenberg, David;
PUBLISHED: 2022, SOURCE: RHEUMATOLOGY, VOLUME: 62, ISSUE: 5
INDEXED IN:
Scopus
WOS
17
TITLE: Assessing outcomes in a lupus nephritis cohort over a 40-year period
AUTHORS: Gisca, E; Duarte, L; Farinha, F; Isenberg, DA;
PUBLISHED: 2021, SOURCE: RHEUMATOLOGY, VOLUME: 60, ISSUE: 4
AUTHORS: Gisca, E; Duarte, L; Farinha, F; Isenberg, DA;
PUBLISHED: 2021, SOURCE: RHEUMATOLOGY, VOLUME: 60, ISSUE: 4
INDEXED IN:
Scopus
WOS
18
TITLE: Anti-protein C antibodies and acquired protein C resistance in SLE: novel markers for thromboembolic events and disease activity?
AUTHORS: Ramirez, GA; Mackie, I; Nallamilli, S; Pires, T; Moll, R; Pericleous, C; Isenberg, DA; Cohen, H; Efthymiou, M;
PUBLISHED: 2021, SOURCE: RHEUMATOLOGY, VOLUME: 60, ISSUE: 3
AUTHORS: Ramirez, GA; Mackie, I; Nallamilli, S; Pires, T; Moll, R; Pericleous, C; Isenberg, DA; Cohen, H; Efthymiou, M;
PUBLISHED: 2021, SOURCE: RHEUMATOLOGY, VOLUME: 60, ISSUE: 3
INDEXED IN:
WOS
19
TITLE: Prevalence and outcome of thrombocytopenia in systemic lupus erythematosus: single-centre cohort analysis
AUTHORS: Pires, TC; Caparros Ruiz, R; Gaspar, P; Isenberg, DA;
PUBLISHED: 2021, SOURCE: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, VOLUME: 39, ISSUE: 3
AUTHORS: Pires, TC; Caparros Ruiz, R; Gaspar, P; Isenberg, DA;
PUBLISHED: 2021, SOURCE: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, VOLUME: 39, ISSUE: 3
INDEXED IN:
WOS
20
TITLE: Fracture risk in systemic lupus erythematosus patients over 28 years
AUTHORS: Garelick, D; Pinto, SM; Farinha, F; Pires, T; Khan, E; Isenberg, D;
PUBLISHED: 2021, SOURCE: RHEUMATOLOGY, VOLUME: 60, ISSUE: 6
AUTHORS: Garelick, D; Pinto, SM; Farinha, F; Pires, T; Khan, E; Isenberg, D;
PUBLISHED: 2021, SOURCE: RHEUMATOLOGY, VOLUME: 60, ISSUE: 6
INDEXED IN:
Scopus
WOS